Capricor Therapeutics
CAPR
#7318
Rank
ยฃ0.42 B
Marketcap
ยฃ7.33
Share price
9.44%
Change (1 day)
73.21%
Change (1 year)

EPS for Capricor Therapeutics (CAPR)

EPS in 2023 (TTM): -ยฃ0.97

According to Capricor Therapeutics 's latest financial reports the company's current EPS (TTM) is -ยฃ1.82. In 2022 the company made an earnings per share (EPS) of -ยฃ0.88 a decrease over its 2021 EPS that were of -ยฃ0.65.

EPS history for Capricor Therapeutics from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ0.9710.4%
2022-ยฃ0.8835.63%
2021-ยฃ0.65-7.45%
2020-ยฃ0.70-55.45%
2019-ยฃ1.57-59.81%
2018-ยฃ3.91-1850%
2017ยฃ0.22-102.94%
2016-ยฃ7.5925.93%
2015-ยฃ6.0355.77%
2014-ยฃ3.87-39.53%
2013-ยฃ6.40-64.78%
2012-ยฃ18.16-62.44%
2011-ยฃ48.35-31.58%
2010-ยฃ70.67-38.71%
2009-ยฃ115.31-43.64%
2008-ยฃ204.58-5.17%
2007-ยฃ215.73427.27%
2006-ยฃ40.92340.33%
2005-ยฃ9.29
2004N/A
2003N/A
2002N/A
2001N/A

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ4.97-372.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ5.24-387.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-ยฃ5.37 194.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ3.24 77.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-ยฃ5.62 208.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-ยฃ21.79 1,095.51%๐Ÿ‡บ๐Ÿ‡ธ USA